LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
New York NY
Legislatures
2023-2024 Regular Session
Assembly
Bills
A05914
NY
New York Assembly Bill A05914
New York 2023-2024 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
NY
New York 2023-2024 Regular Session
New York Assembly Bill A05914
Introduced
3/24/23
Refer
3/24/23
Refer
1/3/24
Caption
Designates Xylazine as a schedule III depressant.
Latest NY A05914 Activity
View All Events: NY 2023-2024 Regular Session A05914
Companion Bills
NY S05439
Same As Designates Xylazine as a schedule III depressant.
Previously Filed As
NY S05421
Designates Xylazine as a schedule III depressant.
NY SB1724
Makes xylazine a Schedule III controlled substance
NY SB465
classifying xylazine as a schedule III controlled drug.
NY S09852
Provides that when a drug is designated or rescheduled by the federal government, it shall be deemed scheduled under NYS law automatically, without further action by the commissioner.
NY HB1881
Adds xylazine to the list of Schedule III controlled substances
NY A10502
Requires polls for special town elections to open on otherwise scheduled general election days, as designated by the state board of elections.
NY HB417
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
NY HB0417
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
NY S2036
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
NY A864
Classifies xylazine as Schedule III controlled dangerous substance under certain circumstances.
Similar Bills
No similar bills found.